These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 35253252)
21. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma. Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704 [TBL] [Abstract][Full Text] [Related]
22. Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays. Coombs CC; Gillis NK; Tan X; Berg JS; Ball M; Balasis ME; Montgomery ND; Bolton KL; Parker JS; Mesa TE; Yoder SJ; Hayward MC; Patel NM; Richards KL; Walko CM; Knepper TC; Soper JT; Weiss J; Grilley-Olson JE; Kim WY; Earp HS; Levine RL; Papaemmanuil E; Zehir A; Hayes DN; Padron E Clin Cancer Res; 2018 Dec; 24(23):5918-5924. PubMed ID: 29866652 [TBL] [Abstract][Full Text] [Related]
23. How clonal are bacteria over time? Shapiro BJ Curr Opin Microbiol; 2016 Jun; 31():116-123. PubMed ID: 27057964 [TBL] [Abstract][Full Text] [Related]
24. Clinical trial designs for evaluating and exploiting cancer evolution. Ingles Garces AH; Porta N; Graham TA; Banerji U Cancer Treat Rev; 2023 Jul; 118():102583. PubMed ID: 37331179 [TBL] [Abstract][Full Text] [Related]
25. Big Bang Tumor Growth and Clonal Evolution. Sun R; Hu Z; Curtis C Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 28710260 [TBL] [Abstract][Full Text] [Related]
27. The life history of 21 breast cancers. Nik-Zainal S; Van Loo P; Wedge DC; Alexandrov LB; Greenman CD; Lau KW; Raine K; Jones D; Marshall J; Ramakrishna M; Shlien A; Cooke SL; Hinton J; Menzies A; Stebbings LA; Leroy C; Jia M; Rance R; Mudie LJ; Gamble SJ; Stephens PJ; McLaren S; Tarpey PS; Papaemmanuil E; Davies HR; Varela I; McBride DJ; Bignell GR; Leung K; Butler AP; Teague JW; Martin S; Jönsson G; Mariani O; Boyault S; Miron P; Fatima A; Langerød A; Aparicio SA; Tutt A; Sieuwerts AM; Borg Å; Thomas G; Salomon AV; Richardson AL; Børresen-Dale AL; Futreal PA; Stratton MR; Campbell PJ; Cell; 2012 May; 149(5):994-1007. PubMed ID: 22608083 [TBL] [Abstract][Full Text] [Related]
28. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing. Jiang Y; Qiu Y; Minn AJ; Zhang NR Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852 [TBL] [Abstract][Full Text] [Related]
30. Adapting clinical paradigms to the challenges of cancer clonal evolution. Murugaesu N; Chew SK; Swanton C Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210 [TBL] [Abstract][Full Text] [Related]
31. Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. Workman P; Al-Lazikani B; Clarke PA Curr Opin Pharmacol; 2013 Aug; 13(4):486-96. PubMed ID: 23810823 [TBL] [Abstract][Full Text] [Related]
32. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment. Brychtová V; Valík V; Vojtěšek B Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018 [TBL] [Abstract][Full Text] [Related]
33. Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan. Salk JJ; Loubet-Senear K; Maritschnegg E; Valentine CC; Williams LN; Higgins JE; Horvat R; Vanderstichele A; Nachmanson D; Baker KT; Emond MJ; Loter E; Tretiakova M; Soussi T; Loeb LA; Zeillinger R; Speiser P; Risques RA Cell Rep; 2019 Jul; 28(1):132-144.e3. PubMed ID: 31269435 [TBL] [Abstract][Full Text] [Related]
34. Somatic clonal evolution: A selection-centric perspective. Scott J; Marusyk A Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395 [TBL] [Abstract][Full Text] [Related]
35. Tumor clonality: research and clinical aspects. Nemtsova MV; Kushlinskii NE Bull Exp Biol Med; 2014 Dec; 158(2):246-51. PubMed ID: 25432282 [TBL] [Abstract][Full Text] [Related]
37. Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing. Kohsaka S; Petronczki M; Solca F; Maemondo M Future Oncol; 2019 Feb; 15(6):637-652. PubMed ID: 30404555 [TBL] [Abstract][Full Text] [Related]
38. Efficient Algorithms Unlock Understanding of Clonal Evolution in Cancer. Miller CA Blood Cancer Discov; 2022 May; 3(3):176-177. PubMed ID: 35510362 [TBL] [Abstract][Full Text] [Related]
39. New paradigms in clonal evolution: punctuated equilibrium in cancer. Cross WCh; Graham TA; Wright NA J Pathol; 2016 Oct; 240(2):126-36. PubMed ID: 27282810 [TBL] [Abstract][Full Text] [Related]
40. Enhancing cancer clonality analysis with integrative genomics. Peterson EA; Bauer MA; Chavan SS; Ashby C; Weinhold N; Heuck CJ; Morgan GJ; Johann DJ BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S7. PubMed ID: 26424171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]